PDS Biotechnology Corp To Host Key Opinion Leader Roundtable Transcript
Ladies and gentlemen, thank you for standing by, and we do thank you for your patience today. Welcome to the PDS Biotechnology webcast, Current and Future Treatments for Recurrent/Metastatic HPV-Positive Head and Neck Cancer. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Dr. Lauren Wood. Dr. Wood, please go ahead.
Thank you, Kevin. Good morning, everyone, and welcome to PDS Biotech's Current and Future Treatments for Recurrent/Metastatic HPV-Positive Head and Neck Cancer and the Potential Application of PDS0101 KOL Web Roundtable Webinar. Again, we apologize for the delay.
With me today are Dr. Ricard Mesia from the Catalan Institute of Oncology; Dr. John Kaczmar from the Medical University of South Carolina; Dr. Katharine Price from Mayo Clinic Comprehensive Cancer Center; and Dr. Glenn Hanna from Dana-Farber Cancer Institute.
I will provide formal introductions in a moment, but before we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |